ClinicalTrials.Veeva

Menu

Effect of Oxygen-supply on 6-Minute-Walking-Distance of COPD III/IV-patients

S

Schön Klinik Berchtesgadener Land

Status

Completed

Conditions

Chronic Obstructive Pulmonary Disease

Treatments

Other: 6MWT with oxygen
Other: 6MWT with medical air

Study type

Interventional

Funder types

Other
Industry

Identifiers

Details and patient eligibility

About

The aim of this study is to investigate the six-minute-walking-distance of COPD-patients with breathing oxygen in comparison to breathing normal air. Patients, who increase their walking-distance about more than 15% or 35m only because of breathing oxygen, are so-called "Oxygen Responders." The study is aimed to find attributes of Oxygen Responder and to investigate, if a patient can change the "respond" with higher performance and endurance.

Enrollment

127 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Chronic obstructive pulmonary disease III/IV

Exclusion criteria

  • Severe exacerbations in the last 4 weeks prior to begin of study (definition of exacerbation: symptoms on more than 3 days with a relevant change in drug therapy (cortisone, antibiotics))
  • Severe exacerbation during rehabilitation
  • Cardiac insufficiency

Trial design

Primary purpose

Screening

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Single Blind

127 participants in 2 patient groups

First of 2 6-minute-walking test with oxygen
Other group
Description:
Continuous flow of 2 liters per minute First with oxygen, second with medical air
Treatment:
Other: 6MWT with medical air
Other: 6MWT with oxygen
First of 2 6-minute-walking tests with medical air
Other group
Description:
Medical air is compressed room air. First test with medical air, second with oxygen
Treatment:
Other: 6MWT with medical air
Other: 6MWT with oxygen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems